ESR1 and breast cancer: The clinical T stage (p < 0.01), cycles of chemotherapy (p = 0.018), pathological T stage (p < 0.001), ER status (p = 0.003), Ki67 (p = 0.034), and the subtype of breast cancer (p = 0.028) after NAC was significantly different between the two groups.